Genzyme pursues innovation in discovery and development and the strategic acquisition of new resources. Our ability to execute creates the opportunities to support long-term growth.

To ensure our long-term growth, we pursue developments globally, as our new research center in the United Kingdom and our worldwide cell therapy joint venture demonstrate. We are also building the capacity and security of our supply chain by more fully globalizing our core competency in manufacturing. We have now created clinical and regulatory affairs hubs in the United Kingdom, the Netherlands and Japan. As 10 new countries have joined the European Union, we have established offices in four of the key cities, ready to work with governments as they increase economic support for improving health-care systems. We engage in such work around the world to bring our products to more patients. Across all our product lines, we are leveraging our global technology, manufacturing, clinical and regulatory, and sales and marketing infrastructures.